DSM-Firmenich's Animal Nutrition Sale Was Harder Than Expected -- Market Talk

Dow Jones

Feb 09

0756 GMT - It took DSM-Firmenich longer than expected to sell its animal nutrition and health business and its deal with CVC Capital Partners for 2.2 billion euros including debt was priced lower than anticipated, Vontobel's Arben Hasanaj says in a research note. The process dragged on, as the prior target for the sale was last year's summer, and price expectations were lowered from the more than 3 billion euros DSM expected at the outset, according to Vontobel. The Dutch ingredients company sought to sell the business given its earnings variability due to vitamin prices and capital demands, the analyst says. Moreover, animal nutrition didn't seem to fit much with the group's core human-focused portfolio, he adds. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

February 09, 2026 02:56 ET (07:56 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610268227"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610268227\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610268227?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-09 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610268227","market":"nz","top_or_hot":-1,"title":"DSM-Firmenich's Animal Nutrition Sale Was Harder Than Expected -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - It took DSM-Firmenich longer than expected to sell its animal nutrition and health business and its deal with CVC Capital Partners for 2.2 billion euros including debt was priced lower than anticipated, Vontobel's Arben Hasanaj says in a research note. The process dragged on, as the prior target for the sale was last year's summer, and price expectations were lowered from the more than 3 billion euros DSM expected at the outset, according to Vontobel. The Dutch ingredients company sought to sell the business given its earnings variability due to vitamin prices and capital demands, the analyst says. Moreover, animal nutrition didn't seem to fit much with the group's core human-focused portfolio, he adds. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 09, 2026 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DSM-Firmenich's Animal Nutrition Sale Was Harder Than Expected -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDSM-Firmenich's Animal Nutrition Sale Was Harder Than Expected -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-09 15:56</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - It took DSM-Firmenich longer than expected to sell its animal nutrition and health business and its deal with CVC Capital Partners for 2.2 billion euros including debt was priced lower than anticipated, Vontobel's Arben Hasanaj says in a research note. The process dragged on, as the prior target for the sale was last year's summer, and price expectations were lowered from the more than 3 billion euros DSM expected at the outset, according to Vontobel. The Dutch ingredients company sought to sell the business given its earnings variability due to vitamin prices and capital demands, the analyst says. Moreover, animal nutrition didn't seem to fit much with the group's core human-focused portfolio, he adds. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 09, 2026 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DSM","symbol_name":"Dreyfus Strategic Municipal Bond","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2610268227","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610268227","pubTimestamp":1770623760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0756 GMT - It took DSM-Firmenich longer than expected to sell its animal nutrition and health business and its deal with CVC Capital Partners for 2.2 billion euros including debt was priced lower than anticipated, Vontobel's Arben Hasanaj says in a research note. The process dragged on, as the prior target for the sale was last year's summer, and price expectations were lowered from the more than 3 billion euros DSM expected at the outset, according to Vontobel. The Dutch ingredients company sought to sell the business given its earnings variability due to vitamin prices and capital demands, the analyst says. Moreover, animal nutrition didn't seem to fit much with the group's core human-focused portfolio, he adds. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DSM":"Dreyfus Strategic Municipal Bond"},"translate_title":"帝斯曼芬美意的动物营养品销售比预期困难——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DSM":1.5},"content_text":"0756 GMT - It took DSM-Firmenich longer than expected to sell its animal nutrition and health business and its deal with CVC Capital Partners for 2.2 billion euros including debt was priced lower than anticipated, Vontobel's Arben Hasanaj says in a research note. The process dragged on, as the prior target for the sale was last year's summer, and price expectations were lowered from the more than 3 billion euros DSM expected at the outset, according to Vontobel. The Dutch ingredients company sought to sell the business given its earnings variability due to vitamin prices and capital demands, the analyst says. Moreover, animal nutrition didn't seem to fit much with the group's core human-focused portfolio, he adds. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 09, 2026 02:56 ET (07:56 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}